Breast cancer has historically been a disease for which immunotherapy was largely unavailable. Recently. the use of immune checkpoint inhibitors (ICIs) in combination with chemotherapy for the treatment of advanced/metastatic triple-negative breast cancer (TNBC) has demonstrated efficacy. including longer progression-free survival and increased overall survival in subsets of patients. https://fitnessgravesyardes.shop/product-category/display-controller/